ImageneBio (IMA) EBT Margin (2020 - 2025)
ImageneBio's (IMA) quarterly EBT Margin came in at 759.62% in Q1 2025, down 735.28% quarter-over-quarter from 90.94% in Q3 2024.
Analysis
ImageneBio (IMA) EBT Margin (2020 - 2025) Analysis & Trends
ImageneBio has disclosed EBT Margin across 6 years of filings, most recently posting 759.62% for Q1 2025.
- In Q1 2025, EBT Margin changed N/A year-over-year to 759.62%; the TTM figure through Sep 2025 stood at 1298.63% (down 58250.0% YoY), while the FY2023 annual figure was 745.94%, down 30565.0% from the prior year.
- EBT Margin came in at 759.62% for Q1 2025 at ImageneBio, down from 90.94% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 13.83% in Q4 2021 to a low of 5376.44% in Q2 2022.
- Average EBT Margin over 5 years is 988.0%, with a median of 372.4% recorded in 2021.
- Year-over-year, EBT Margin jumped 4009537 bps in 2021 and plunged 501913 bps in 2022.
- Over 5 years, EBT Margin stood at 13.83% in 2021, then slumped by 1970 bps to 258.66% in 2022, then sank by 1053 bps to 2981.94% in 2023, then jumped by 97 bps to 90.94% in 2024, then tumbled by 735 bps to 759.62% in 2025.
- Per Business Quant data, the three most recent EBT Margin figures were 759.62% in Q1 2025, 90.94% in Q3 2024, and 2981.94% in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 27.53% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -131.41% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 41.75% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 35.61% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 35.78% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -528.97% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 13.77% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 4.84% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -20,427.46% |
| 10 | ImageneBio | 42.89 Mn | -92.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -759.63% |
| Sep 30, 2024 | -90.94% |
| Dec 31, 2023 | -2,981.94% |
| Sep 30, 2023 | -1,463.54% |
| Jun 30, 2023 | -854.04% |
| Mar 31, 2023 | -267.63% |
| Dec 31, 2022 | -258.66% |
| Sep 30, 2022 | -270.82% |
| Jun 30, 2022 | -5,376.44% |
| Mar 31, 2022 | -497.61% |
| Dec 31, 2021 | 13.83% |
| Sep 30, 2021 | -387.48% |
| Jun 30, 2021 | -357.31% |
| Mar 31, 2021 | -279.79% |
| Dec 31, 2020 | -40,081.54% |
| Sep 30, 2020 | -220.33% |
| Jun 30, 2020 | -164.63% |
| Mar 31, 2020 | -222.37% |